Profile: Cytogen Corporation is a specialty pharmaceutical company dedicated to advance the treatment and care of cancer patients by building, developing, and commercializing a portfolio of oncology products. Caphosol® is a topical oral agent indicated as an adjunct to standard oral care in treating oral mucositis caused by radiation and chemotherapy. Caphosol® is also indicated for dryness of the mouth and dryness of the throat (xerostomia) regardless of the cause, whether the conditions are temporary or permanent. Quadramet® is a radiopharmaceutical for the treatment of pain in patients, whose cancer has spread to the bone. Prostascint® is a PSMA-targeting monoclonal antibody-based agent used to prevent the spread of prostate cancer. Prostate-specific membrane antigen (PSMA) is a protein that is highly expressed on the surface of prostate cancer cells and the neovasculature of solid tumors.